Today I added a small initial stake in Mylan (MYL) to my portforlio. Note my trading activities are nowhere near large enough to effect stock prices.
I wrote a positive article about Mylan at Seeking Alpha, Mylan Pursues Global Generics Dominance Strategy, back on September 6, 2013. The price is way up since then. I now wish I had bought MYL back then.
Still, today's price in the $52 range is well off the 52 week high of $57.52. If it goes cheaper (without good reason) I'll buy more when the opportunity arises.
Mylan is a large cap (near $20 billion) company that manufactures and markets generic drugs. I am better known for writing and investing in small caps like Dot Hill, Adept Technologies, and Inovio. But most of my portfolio is in middle and large cap stocks.
While I don't plan to write another article on Mylan anytime soon, I am covering their analyst conferences, and your are always welcome to read my summaries at:
Mylan analyst conference call summaries
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment